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Summary
The data presented in this paper describe trends in treated problem cocaine use in 
Ireland between 2002 and 2007. The paper describes treated problem cocaine use in 
relation to person, place and time. The analysis presented is based on data reported to 
the National Drug Treatment Reporting System (NDTRS). It is important to note that 
the NDTRS collects data on episodes of treatment in a calendar year, rather than on 
the individual person treated. This means that individuals may appear in the figures 
more than once if they receive treatment at more than one centre or at the same 
centre more than once per year.
The main findings and their implications are:
One-fifth (10,764) of all cases treated for problem drug use between 2002 and 
2007 reported cocaine as a problem substance. The annual number of cocaine cases 
increased by 177%, from 954 in 2002 to 2,643 in 2007. This increase was in line with 
increases in cocaine seizures, in cocaine use among the general population and in 
cocaine-related deaths during the same time period.
The number of cases who reported cocaine as their main problem substance 
increased by 502%, from 128 in 2002 to 770 in 2007. The number of cases who 
reported cocaine as an additional problem substance increased by 128%, from 826 
in 2002 to 1,885 in 2007. 
The prevalence and incidence of treated problem cocaine use reported in this paper 
are based on the numbers reporting cocaine as their main problem substance. The 
prevalence of treated problem cocaine use among 15–64-year-olds living in Ireland 
increased from nine per 100,000 in 2002 to 25 per 100,000 in 2007. This indicates 
that problem cocaine use is a recurring addiction that requires repeated episodes 
of treatment over time. The incidence of treated problem cocaine use among 
15–64-year-olds living in Ireland increased steadily from five per 100,000 in 2002 
to 15 in 2007. Increasing numbers of new cocaine cases entering treatment is an 
indicator of recent trends in problem cocaine use in the population. The increase in 
the number of cocaine cases recorded can be explained by a combination of factors: 
an increase in the number of treatment places, an increase in cocaine use among the 
population and an increase in reporting to the NDTRS.
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The average annual incidence of treated problem cocaine use for the period 2002–2007 was highest in 
Wexford, Louth, Waterford and Carlow (with over 15 cases per 100,000 of the 15–64-year-old population), 
followed by Cork, Cavan, Limerick, Kildare and Meath (with between 10 and 13 cases per 100,000). The 
incidence was lowest in counties located mainly in the west and north-west of the country (with between 
2 and 4 cases per 100,000). The incidence was lower than expected in Dublin due to the fact than many 
problem cocaine users in Dublin also used opiates; in such cases the opiate is recorded as the main problem 
substance and cocaine as an additional problem substance.
While the majority of cocaine cases each year were treated in outpatient services, the number and 
proportion treated in inpatient services increased gradually over the period. In 2007, 69% of cases were 
treated as outpatients and 28% as inpatients. Of the 770 cases entering treatment in 2007 who reported 
cocaine as their main problem substance, 84% received counselling, 43% a brief intervention, 31% 
complementary therapy and 27% a medication-free therapy. Almost 60% of cases received more than 
one initial treatment intervention. It is widely recognised that no single intervention will effectively treat 
problem cocaine use.
Of the 10,764 reported cases in the years 2002 to 2007, almost three-fifths (59%, 6,352) did not specify 
the type of cocaine used. Of the 4,516 cases who did do so, 3,977 (88%) used powder cocaine and 539 
(12%) used crack cocaine. One hundred and four of these cases reported use of both forms of cocaine, of 
whom 34 reported one form as their main problem substance and another form as an additional problem 
substance, and 70 reported both forms of cocaine as additional problem substances.
More than four out of five cases who reported cocaine as their main problem substance used more than 
one drug, although the proportion of such cases decreased from 92% in 2002 to 79% in 2007. It is 
generally accepted that polysubstance use increases the complexity of these cases and is associated with 
poorer treatment outcomes. Cannabis (58%), alcohol (56%) and ecstasy (32%) were the most common 
additional problem substances reported by cases entering treatment in 2007 who reported cocaine as their 
main problem substance. The main problem substances associated with cocaine as an additional problem 
substance were opiates (51%) and, to a lesser extent, alcohol (29%) and cannabis (15%). There appeared to 
be two patterns of cocaine use among those entering treatment: use of opiates alongside cocaine and use 
of combinations of alcohol, cannabis and ecstasy alongside cocaine. The use of alcohol and cocaine together 
leads to the formation of a third drug, cocaethylene, which is a more stable compound than the normal 
by-product of cocaine and is effective for longer in the body. There is evidence to show that cocaethylene 
increases the incidence and intensity of the cardiovascular and behavioural side effects of cocaine.
Of the 770 cases treated in 2007 who reported cocaine as their main problem substance, 81% snorted it, 
13% smoked it, and 4% injected it. Most of the injectors were current or former opiate injectors. Cocaine 
powder is usually snorted, while crack cocaine is usually smoked; both forms of cocaine can be injected. As 
is the case with injecting, snorting cocaine poses a risk for the transmission of blood-borne viruses as there 
is a risk of bleeding and sharing equipment while using the drug.
Of the 770 cases treated in 2007 who reported cocaine as their main problem substance, 13% used it daily, 
44% used it on two to six days per week, 11% used it once per week or less and 30% had not used it in 
the month prior to entering treatment. The fact that the majority of cases reported using cocaine on two to 
six days per week indicates that cocaine may be used as a week-end drug or as part of a binge.
The median age of previously treated cases who reported cocaine as their main problem substance 
decreased from 28 to 27 years between 2002 and 2007. In the same period, less than 2% of previously 
treated cases were aged under 18 years. Five per cent of new cases in 2007 were aged under 18 years, 
a notable increase on previous years. This may be due to the increase in adolescent treatment services in 
2007. In the six-year period, 83% of all cases entering treatment were male and one-third were employed. 
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Glossary
Powder cocaine• , or cocaine hydrochloride, is the most commonly used form of cocaine. It is a white 
crystalline powder which can be snorted through the nose or which, when dissolved in water, can be 
injected.
Crack cocaine•  is a smokeable form of cocaine obtained by heating ordinary cocaine powder in a 
solution of baking soda until the water evaporates and crystals are formed. Crack cocaine vaporises at 
a low temperature so it can be easily inhaled via a heated pipe.
The • median is the value at the mid–point in a sequence of numerical values ranged in ascending or 
descending order. It is defined as the value above or below which half of the values lie. Unlike the 
mean (average), the median is not influenced by extreme values (or outliers). For example, in the 
case of five drug users aged 22, 23, 24, 24 and 46 years respectively, the median (middle value) is 
24 years, whereas the mean is 27.8 years. While both the median and the mean describe the central 
value of the data, the median is more useful in this case because the mean is influenced by the one 
older person in this example. 
Incidence•  is the number of new cases of disease or events that develop among a population during 
a specified time interval. As an example, in 2007, in a county with a population of 31,182, 10 opiate 
users sought treatment for the first time in 2007. The incidence is the number of new cases treated 
divided by the county population, expressed per given number of the population, i.e., per 100, per 
1,000, per 10,000, per 100,000 etc. 
The rate in this example may be calculated as follows: (10/31,182) x 100,000, which gives an 
incidence rate of 32 per 100,000 of the county population in 2007.
Prevalence•  is the proportion of people in a population who have a disease or condition at a specific 
point or period in time. As an example, in 2007, in a county with a population of 31,182, 10 opiate 
users sought treatment for the first time, 20 returned to treatment and five continued in treatment 
from the previous year, giving a total of 35 people treated for problem opiate use in the year. The 
prevalence is the total number of cases divided by the county population, expressed per given 
number of the population, i.e., per 100, per 1,000, per 10,000, per 100,000 etc. 
The rate in this example may be calculated as follows: (35/31,182) x 100,000, which gives a 
prevalence rate of 112 per 100,000 of the county population in 2007.
Epidemic•  disease levels exist when there is an excess number of new cases among a specific 
population for that point and place in time. An epidemic can also be called an outbreak. An excess 
number of cases is defined as a number greater than two standard deviations above the norm 
expected for that point in time. 
Health Service Executive (HSE)• 
On 1 January 2005, the 10 health boards managing the health services in Ireland were replaced  –
by a single entity, the Health Service Executive (HSE). The former health boards were responsible 
for health care provision to populations in specific geographical areas. In the interest of continuity 
of care, the HSE maintained these 10 areas for an interim period and called them HSE areas. The 
former Eastern Regional Health Authority was known as the HSE Eastern Region for this interim 
period. 
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The table below presents the past health board structure and the interim HSE area structure: –
Regional Health Authority Health boards HSE areas
Not applicable North Eastern Health Board HSE North Eastern Area
Eastern Regional Health Authority (ERHA*) Northern Area Health Board HSE Northern Area
Eastern Regional Health Authority (ERHA) East Coast Area Health Board HSE East Coast Area
Eastern Regional Health Authority (ERHA) South Western Area Health Board HSE South Western Area
Not applicable Midland Health Board HSE Midland Area
Not applicable South Eastern Health Board HSE South Eastern Area
Not applicable Southern Health Board HSE Southern Area
Not applicable Mid–Western Health Board HSE Mid-Western Area
Not applicable North Western Health Board HSE North Western Area
Not applicable Western Health Board HSE Western Area
*The ERHA was known as the HSE Eastern Region for the interim period
Following a number of years of re-structuring, health care is now provided through four HSE  –
regions and 32 local health offices (LHOs). The local health offices are based on the geographical 
boundaries of the former community care areas. The table below presents the current HSE 
structure:
HSE regions Local health offices
HSE Dublin 
North East 
North West Dublin
North Central Dublin
North Dublin
Cavan/Monaghan
Louth
Meath
HSE Dublin 
Mid-Leinster 
Dublin South
Dublin South East
Dublin South City
Dublin South West
Dublin West
Kildare/West Wicklow
Wicklow
Longford/Westmeath
Laois/Offaly
HSE South
Cork South Lee
Cork North Lee
West Cork
North Cork
Kerry
Carlow/Kilkenny
Tipperary South 
Waterford
Wexford
HSE West
Donegal
Sligo/Leitrim/West Cavan
Galway
Mayo
Roscommon
Tipperary North/East Limerick
Limerick
Clare
The data in this paper relating to the average annual incidence of treated problem substance use  –
and place of residence of treated cases living in Ireland are presented by HSE region and by former 
health board area. Each of the four HSE regions is made up of a number of former health board 
areas and can be easily divided along their boundaries. It is also worth noting that the 10 regional 
drugs task forces were created to service the areas covered by the former health boards.
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Introduction
The National Drug Treatment Reporting System (NDTRS) is an epidemiological database on treated drug 
and alcohol misuse in Ireland. It is co-ordinated by staff at the Alcohol and Drug Research Unit (ADRU) 
of the Health Research Board (HRB) on behalf of the Department of Health and Children. The monitoring 
role of the NDTRS is recognised by the Government in its document Building on experience: National Drugs 
Strategy 2001–2008. The collection and reporting of data to the NDTRS is one of the actions identified and 
agreed by Government for implementation by the former health boards (now HSE regions): ‘All treatment 
providers should co-operate in returning information on problem drug use to the Drug Misuse Research 
Division [now ADRU] of the HRB’ (Department of Tourism, Sport and Recreation 2001: 118). 
The NDTRS was established in 1990 in the Greater Dublin Area and was extended in 1995 to cover all 
areas of the country. It was developed in line with the Pompidou Group’s Definitive Protocol (Hartnoll 
1994) and subsequently refined in accordance with the Treatment Demand Indicator Protocol (EMCDDA 
and Pompidou Group 2000). Originally designed to record drug misuse, the NDTRS recorded problematic 
use of alcohol only in cases where it was an additional problem substance, that is, where the client’s 
main reason for entering treatment was drug misuse but he/she also reported problematic use of alcohol. 
However, it became increasingly evident that alcohol was the main problem substance in Ireland and 
that a large proportion of cases used both alcohol and drugs (Long et al. 2004). In parts of the country, 
particularly outside Dublin, alcohol and drug treatment services are integrated. Failure to include alcohol 
data in reporting systems leads to an underestimation of problem substance use, and of the workload of 
addiction services (Long et al. 2004). In recognition of this, the remit of the NDTRS was extended in 2004 
to include cases where alcohol is recorded as the main or only reason for seeking treatment. The overlap 
between problem alcohol and drug use has been identified in the current strategic plans of a number of 
drugs task forces, which have emphasised the need for treatment services that can address the many forms 
of polysubstance use.
Drug and alcohol treatment data are viewed as an indirect indicator of drug and alcohol misuse as well 
as a direct indicator of demand for treatment services. NDTRS data are used at national level (alcohol 
and drug data) and at European level (drug data) to provide information on the characteristics of clients 
entering treatment and on patterns of substance misuse, such as types of substance used and consumption 
behaviours. Drug data are ‘valuable from a public health perspective to assess needs, … and to plan and 
evaluate services’ (EMCDDA 1998: 23). 
Information from the NDTRS is made available to service providers and policy makers and is used to inform 
local and national substance misuse policy and planning. In 1996, NDTRS data were used to identify a 
number of local areas with problematic heroin use (Ministerial Task Force 1996). These areas were later 
designated as local drugs task force (LDTF) areas, and continue to co-ordinate strategic responses to 
drug misuse in their communities. Again, in 2004, NDTRS data were used to describe treatment-seeking 
characteristics and behaviours of those aged under 18 years, and to inform the deliberations of the Working 
Group on the need for a specific treatment approach (Working Group on treatment of under 18 year olds 
2005). In more recent years, NDTRS data have been used to inform some of the recommendations of the 
Working Group on Drugs Rehabilitation (2007), and, by the Working Group on residential services, to help 
estimate the number of residential places required to address severe alcohol and drug problems in Ireland 
(Corrigan and O’Gorman 2007). The Comptroller and Auditor General (2009) used data from the reporting 
system in a special report which examined treatment and rehabilitation services provided for people with 
drug addictions.
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The National Advisory Committee on Drugs (NACD) and the Department of Health, Social Services and 
Public Safety (Northern Ireland) published jointly the results of two successive all-Ireland general population 
drug prevalence surveys which provide another view of cocaine use in Ireland (NACD and DAIRU 2006, 
2008). The 2006/7 survey found that cocaine use had increased overall compared to the 2002/3 survey 
(Table 1). The proportion of adults who reported using cocaine (including crack) at some point in their 
lives increased from 3% in 2002/3 to 5% in 2006/7. The proportion of young adults who reported using 
cocaine in their lifetime also increased, from 5% in 2002/3 to 8% in 2006/7. As expected, more men (7%) 
than women (3.5%) reported using cocaine in their lifetime. The proportion of adults who reported using 
cocaine in the last year increased from 1% in 2002/3 to 2% in 2006/7 (Table 1). The proportion of young 
adults who reported using cocaine in the last year increased from 2% in 2002/3 to 3% in 2006/7. 
Table 1 Prevalence of cocaine use (including crack) among the general population in Ireland, 
2002/3 and 2006/7
Adults
15–64 years
%
Males
15–64 years
%
Females
15–64 years
%
Young adults
15–34 years
%
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime (ever used) 3.0 5.3 4.3 7.0 1.6 3.5 4.7 8.2
Last year (recent use) 1.1 1.7 1.7 2.3 0.5 1.0 2.0 3.1
Last month (current use) 0.3 0.5 0.7 0.8 0.0 0.2 0.7 1.0
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2006, 2008)
According to data from the National Drug-Related Deaths Index, the number of poisoning deaths in which 
cocaine was implicated, alone or with another drug, increased steadily from five in 1998 to 34 in 2005 
(Lyons et al. 2008). In that eight-year period, cocaine was involved in 100 deaths by poisoning, accounting 
for 6.4% of the total number of poisonings. Of these 100 deaths, 29 were due to cocaine alone. Heroin 
and/or methadone were often associated with cocaine in cases of polysubstance poisoning. 
The number of cocaine seizures increased steadily, from 566 in 2003 to 1,749 in 2007 (CSO 2009). 
Methods
Treatment for problem cocaine use in Ireland is provided by statutory and non-statutory services, including 
residential centres, community-based addiction services, general practices and prison services. 
For the purpose of the NDTRS, treatment is broadly defined as any activity which aims to ameliorate the 
psychological, medical or social state of individuals who seek help for their substance misuse problems. 
Clients who attend needle-exchange services are not included in this reporting system. Cocaine treatment 
options include one or more of the following: medication (psychiatric treatment), brief intervention, 
counselling (including cognitive behavioural therapy), medication–free therapy, family therapy, 
complementary therapy, and/or life-skills training.
Compliance with the NDTRS requires that one form be completed for each new client coming for first 
treatment and for each previously treated client returning to treatment for problem substance use. Service 
providers at treatment centres throughout Ireland collect data on episodes of treatment in a calendar year, 
rather than on the individual person treated.
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Staff at the ADRU of the HRB compile anonymous, aggregated data, which are analysed and reported at 
national and EU levels.
The main elements of the reporting system in the context of this paper are defined as follows: 
All cases treated – describes individuals who receive treatment for problem cocaine use at each treatment 
centre in a calendar year, and includes: 
Previously treated cases –  – describes individuals who were treated previously for problem cocaine or 
other drug use at any treatment centre and have returned to treatment for problem cocaine use in 
the reporting year; 
New cases treated –  – describes individuals who have never been treated for problem cocaine or 
other drug use; and
Status unknown –  – describes individuals whose status with respect to previous treatment for 
problem cocaine or other drug use is not known.
In the case of the data for ‘previously treated cases’, there is a possibility that individuals appear more than 
once in the database; for example, where a person receives treatment at more than one centre or at the 
same centre more than once per year. 
Analysis
The analysis provides an outline of the following: service provision for treated cocaine users; numbers 
treated; incidence and prevalence of treatment by year and by place of residence; additional problem 
substances; patterns of cocaine use; socio-demographic characteristics; and initial treatment intervention(s) 
provided. 
Service provision
The total number of cases reporting cocaine as a problem substance increased by 177%, from 954 in 
2002 to 2,643 in 2007 (Table 2). While the majority of cocaine cases each year were treated in outpatient 
services, the number and proportion treated in inpatient services increased steadily over the period. In 
2007, 69% were treated as outpatients and 28% as inpatients. Small numbers of cocaine cases were treated 
in low-threshold and general practice settings in the years 2002–2007; these cases were also treated for 
opiate use.
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Table 2 Cocaine cases entering treatment* by type of service provider (NDTRS 2002–2007) 
2002 2003 2004 2005 2006 2007
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 954 1336 1602 1974 2255 2643
Outpatient 705 (73.9) 950 (71.1) 1079 (67.4) 1391 (70.5) 1608 (71.3) 1820 (68.9)
Inpatient 152 (15.9) 270 (20.2) 394 (24.6) 496 (25.1) 580 (25.7) 746 (28.2)
Low-threshold† 35 (3.7) 43 (3.2) 74 (4.6) 46 (2.3) 25 (1.1) 31 (1.2)
General practitioner 61 (6.4) 72 (5.4) 55 (3.4) 41 (2.1) 42 (1.9) 46 (1.7)
Service type unknown‡ 1 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
* Excludes cases not normally resident in Ireland.
† Low-threshold services provide low-dose methadone or drop-in facilities only.
‡ Relevant data not recorded on the NDTRS forms returned.
Numbers treated and type of cocaine used
One-fifth (10,764) of all cases treated for problem substance use between 2002 and 2007 reported cocaine 
as a main or an additional problem substance (Table 3). The number of cases who reported cocaine as 
their main problem substance increased by 502%, from 128 in 2002 to 770 in 2007 (Table 4). The 
number of cases who reported cocaine as an additional problem substance increased by 128%, from 826 
in 2002 to 1,885 in 2007 (Table 5). 
Of the 10,764 cocaine cases treated in the years 2002–2007, almost three-fifths (59%, 6,352) did not 
specify the type of cocaine used. Of the 4,516 cases who did do so, 3,977 (88%) used powder cocaine and 
539 (12%) used crack cocaine. One hundred and four of these cases reported use of both forms of cocaine, 
of whom 34 reported one form as their main problem substance and another form as an additional 
problem substance, and 70 reported both forms of cocaine as additional problem substances.
The number of previously treated cases who reported using powder cocaine increased from 28 in 2002 
to 715 in 2006, and to 864 in 2007 (Table 3). The sharp increase in the figures for powder cocaine use in 
2006 and 2007 and the parallel drop in figures for use of cocaine of unspecified type were due to a data 
correction. This correction took effect from 2006 onwards, whereby cases who did not specify the cocaine 
type used, but who reported snorting cocaine, were recorded as cocaine powder users (crack cocaine 
cannot be consumed by snorting). 
The number of cases who specified crack cocaine as a problem substance increased from 57 in 2002 to 223 
in 2007. While this increase reflects a rise in the numbers reporting crack cocaine use in Ireland in recent 
years, it is also partly due to increased accuracy in data reporting to the NDTRS. Data providers were made 
aware of the importance of more accurate recording of data and were requested to specify the type of 
cocaine used by clients where possible. 
Throughout the reporting period, crack cocaine use was more commonly reported by previously treated 
cases than by new cases; it was also more common as an additional problem substance than as a main 
problem substance. In general, crack cocaine appears to be associated with opiate use (Connolly et al. 
2008).
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Table 3 Cocaine cases entering treatment* by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 954 1336 1602 1974 2255 2643
Cocaine type unspecified 863 (90.5) 1221 (91.4) 1493 (93.2) 1798 (91.1) 536 (23.8) 441 (16.7)
Cocaine powder 42 (4.4) 56 (4.2) 64 (4.0) 137 (6.9) 1667 (73.9) 2011 (76.1)
Crack cocaine 57 (6.0) 71 (5.3) 57 (3.6) 61 (3.1) 70 (3.1) 223 (8.4)
Previously treated cases 546 740 846 1010 1134 1294
Cocaine type unspecified 485 (88.8) 671 (90.7) 772 (91.3) 922 (91.3) 388 (34.2) 312 (24.1)
Cocaine powder 28 (5.1) 29 (3.9) 39 (4.6) 64 (6.3) 715 (63.1) 864 (66.8)
Crack cocaine 35 (6.4) 46 (6.2) 43 (5.1) 38 (3.8) 41 (3.6) 136 (10.5)
New cases 362 565 709 915 1037 1299
Cocaine type unspecified 338 (93.4) 526 (93.1) 681 (96.1) 827 (90.4) 113 (10.9) 120 (9.2)
Cocaine powder 12 (3.3) 24 (4.2) 20 (2.8) 73 (8.0) 907 (87.5) 1108 (85.3)
Crack cocaine 18 (5.0) 19 (3.4) 11 (1.6) 23 (2.5) 25 (2.4) 81 (6.2)
Treatment status unknown 46 31 47 49 84 50
* Excludes cases not normally resident in Ireland.
Table 4 Cases entering treatment* who reported cocaine as their main problem substance, 
by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
Cocaine type unspecified 121 (94.5) 235 (92.9) 312 (94.3) 420 (89.9) 77 (13.9) 75 (9.7)
Cocaine powder 5 (3.9) 9 (3.6) 11 (3.3) 39 (8.4) 459 (83.2) 646 (83.9)
Crack cocaine 2 (1.6) 9 (3.6) 8 (2.4) 8 (1.7) 16 (2.9) 49 (6.4)
Previously treated cases 56 96 119 175 194 290
Cocaine type unspecified 52 (92.9) 86 (89.6) 106 (89.1) 149 (85.1) 38 (19.6) 36 (12.4)
Cocaine powder 3 (5.4) 5 (5.2) 8 (6.7) 22 (12.6) 151 (77.8) 224 (77.2)
Crack cocaine 1 (1.8) 5 (5.2) 5 (4.2) 4 (2.3) 5 (2.6) 30 (10.3)
New cases 61 148 195 275 342 462
Cocaine type unspecified 59 (96.7) 141 (95.3) 189 (96.9) 254 (92.4) 37 (10.8) 34 (7.4)
Cocaine powder 1 (1.6) 3 (2.0) 3 (1.5) 17 (6.2) 295 (86.3) 410 (88.7)
Crack cocaine 1 (1.6) 4 (2.7) 3 (1.5) 4 (1.5) 10 (2.9) 18 (3.9)
* Excludes cases not normally resident in Ireland.
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Table 5 Cases entering treatment* who reported cocaine as an additional problem substance, 
by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 826 1084 1274 1516 1712 1885
Cocaine type unspecified 742 (89.8) 986 (91.0) 1181 (92.7) 1378 (90.9) 459 (26.8) 366 (19.4)
Cocaine powder 37 (4.5) 47 (4.3) 53 (4.2) 98 (6.5) 1208 (70.6) 1365 (72.4)
Crack cocaine 55 (6.7) 62 (5.7) 49 (3.8) 53 (3.5) 54 (3.2) 174 (9.2)
Previously treated cases 490 644 728 840 944 1014
Cocaine type unspecified 433 (88.4) 585 (90.8) 666 (91.5) 773 (92.0) 350 (37.1) 276 (27.2)
Cocaine powder 25 (5.1) 24 (3.7) 31 (4.3) 42 (5.0) 564 (59.7) 640 (63.1)
Crack cocaine 34 (6.9) 41 (6.4) 38 (5.2) 34 (4.0) 36 (3.8) 106 (10.5)
New cases 301 418 516 644 700 839
Cocaine type unspecified 279 (92.7) 385 (92.1) 492 (95.3) 573 (89.0) 76 (10.9) 86 (10.3)
Cocaine powder 11 (3.7) 21 (5.0) 17 (3.3) 56 (8.7) 612 (87.4) 698 (83.2)
Crack cocaine 17 (5.6) 15 (3.6) 8 (1.6) 19 (3.0) 15 (2.1) 63 (7.5)
* Excludes cases not normally resident in Ireland.
Incidence and prevalence of treated cocaine use by year
Annual rates for the incidence (new cases) and prevalence (all cases) of treated cocaine use are expressed 
per 100,000 of the population aged 15–64 years, based on the census figures for 2002 and 2006 and CSO 
estimated figures for 2007 (CSO 2007, 2008). 
Figure 1 presents the annual incidence and prevalence rates of cases treated for cocaine as a main problem 
substance. The prevalence increased from nine in 2002 to 25 in 2007. This indicates that problem cocaine 
use is a chronic, recurring health condition that requires repeated episodes of treatment over time. The 
incidence increased from five in 2002 to 15 in 2007. The numbers of new cases entering treatment are an 
indirect indicator of recent trends and, along with the results of the NACD general population survey, point 
to an increase in cocaine use during this period.
Figure 1 Incidence and prevalence of cases treated for cocaine as their main problem substance, 
per 100,000 15–64-year-olds (NDTRS 2002–2007; CSO 2007, 2008) 
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Incidence and prevalence of treated cocaine use by place of residence
Table 6 presents the number of cases entering treatment who reported cocaine as their main problem 
substance, by year, by HSE region of residence and by treatment status. In 2007, one-third of cases who 
reported cocaine as their main problem substance lived in the HSE South Region, and 31% lived in the HSE 
Dublin Mid-Leinster Region. Less than one-fifth of cases lived in the HSE Dublin North East and in the HSE 
West regions.
Table 6 Cases entering treatment* who reported cocaine as their main problem substance, by HSE 
region of residence and by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
HSE region of residence n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
Dublin North East 34 (26.6) 58 (22.9) 120 (36.3) 109 (23.3) 147 (26.6) 151 (19.6)
Dublin Mid-Leinster 27 (21.1) 55 (21.7) 94 (28.4) 137 (29.3) 172 (31.2) 239 (31.0)
South 44 (34.4) 102 (40.3) 89 (26.9) 167 (35.8) 171 (31.0) 256 (33.2)
West 23 (18.0) 38 (15.0) 28 (8.5) 54 (11.6) 62 (11.2) 124 (16.1)
Previously treated cases 56 96 119 175 194 290
Dublin North East 17 (30.4) 31 (32.3) 41 (34.5) 47 (26.9) 43 (22.2) 64 (22.1)
Dublin Mid-Leinster 15 (26.8) 24 (25.0) 55 (46.2) 68 (38.9) 71 (36.6) 97 (33.4)
South 14 (25.0) 32 (33.3) 19 (16.0) 46 (26.3) 60 (30.9) 90 (31.0)
West 10 (17.9) 9 (9.4) 4 (3.4) 14 (8.0) 20 (10.3) 39 (13.4)
New cases 61 148 195 275 342 462
Dublin North East 16 (26.2) 25 (16.9) 73 (37.4) 58 (21.1) 95 (27.8) 81 (17.5)
Dublin Mid-Leinster 10 (16.4) 29 (19.6) 35 (17.9) 63 (22.9) 96 (28.1) 133 (28.8)
South 26 (42.6) 66 (44.6) 67 (34.4) 118 (42.9) 110 (32.2) 165 (35.7)
West 9 (14.8) 28 (18.9) 20 (10.3) 36 (13.1) 41 (12.0) 83 (18.0)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
Table 7 presents the number of new cases entering treatment in the period 2002–2007 who reported cocaine 
as their main problem substance, by regional drugs task force (RDTF) area of residence. The Southern, South 
Eastern and South Western RDTF areas reported the highest numbers of such cases. The North Western and 
East Coast areas reported the lowest numbers. The lower than expected number of new cocaine cases in the 
East Coast RDTF area may be due to the fact that cocaine use was frequently reported in that region as an 
additional problem substance by cases whose main problem substance was an opiate (see Table 11).
Table 7 New cases entering treatment* who reported cocaine as their main problem substance, 
by regional drugs task force (RDTF) area of residence (NDTRS 2002–2007)
RDTF area of residence Number (%)
All new cases 1483 (100.0)
Southern 288 (19.6)
South East 276 (18.8)
South West (of Dublin and Wicklow and all of Kildare) 250 (17.0)
North Eastern 174 (11.8)
North Dublin City and County 174 (11.8)
Mid West 122 (8.3)
Western 65 (4.4)
Midland 58 (3.9)
East Coast (of Dublin and Wicklow) 34 (2.3)
North West 30 (2.0)
RDTF area unknown 12
* Excludes cases not normally resident in Ireland.
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In 1996, NDTRS data were used to identify a number of local areas with problematic heroin use (Ministerial 
Task Force 1996). These areas were later designated as local drugs task force (LDTF) areas. The number 
of new cocaine cases entering treatment for cocaine as their main problem substance was highest in the 
Tallaght LDTF area, followed by the North Inner City and Dublin North East LDTF areas (Table 8). The 
lowest numbers of cases lived in the Ballyfermot and Canal Communities LDTF areas. The lower than 
expected number of new cocaine cases in some Dublin LDTF areas may be due to the fact that cocaine use 
was frequently reported in those areas as an additional problem substance by cases whose main problem 
substance was an opiate (Table 11). In addition, the numbers reported for each area were influenced by 
treatment availability in the area, and by the extent to which the area services participated in the NDTRS.
Table 8 New cases entering treatment* who reported cocaine as their main problem substance, 
by local drugs task force (LDTF) (or other) area of residence (NDTRS 2002–2007)
LDTF (or other) area of residence Number (%)
All new cases 1483 (100.0)
Tallaght 69 (4.7)
North Inner City 49 (3.3)
Dublin North East 43 (2.9)
Dublin 12 39 (2.6)
Finglas-Cabra 25 (1.7)
Clondalkin 24 (1.6)
Dun Laoghaire–Rathdown 18 (1.2)
South Inner City 18 (1.2)
Blanchardstown 16 (1.1)
Ballymun 11 (0.7)
Bray 7 (0.5)
Ballyfermot 5 (0.3)
Canal Communities 4 (0.3)
Rest of Dublin 49 (3.3)
Outside Dublin (excluding Bray) 1106 (74.5)
* Excludes cases not normally resident in Ireland.
In order to adjust for variation in population size by geographical area, the actual incidence of treated 
cocaine use in each area was calculated using the average number of new cases over the six-year period 
living in each of the 10 regional drugs task force areas, 26 counties and 32 local health office areas; this 
average was divided by the population aged 15–64 years living in the respective regional drugs task force 
areas and counties, using the census figures for 2002 and 2006 and CSO estimated figures for 2007, and 
for local health office areas using CSO figures for 2006 only and estimated figures for 2007 (CSO 2008). 
For the period 2002–2007, the average annual incidence of new cases treated for cocaine as their main 
problem substance was highest in the South Eastern RDTF area (at 16 cases per 100,000), followed by the 
Southern and North Eastern areas (at 12 cases) (Figure 2). The East Coast RDTF area had the lowest average 
annual incidence, at 2 cases per 100,000.
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Figure 2 Average annual incidence of cases treated for cocaine as a main problem substance per 
100,000 15–64-year-olds, by regional drugs task force area of residence (NDTRS 2002–
2007; CSO 2007, 2008)
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Treatment data analysed by county indicate that the highest numbers of new cases reporting cocaine as 
their main problem substance between 2002 and 2007 lived in the main cities of Dublin and Cork (Table 
9). The lowest numbers lived in Leitrim, Monaghan and Longford. 
Table 9 New cases entering treatment* who reported cocaine as their main problem substance, 
by county of residence (NDTRS 2002–2007)
County of residence Number (%)
All new cases 1483 (100.0)
Dublin 370 (25.4)
Cork 258 (17.4)
Wexford 111 (7.5)
Limerick 81 (5.5)
Louth 80 (5.4)
Kildare 79 (5.3)
Waterford 76 (5.1)
Meath 63 (4.2)
Galway 40 (2.7)
Carlow 34 (2.3)
Kerry 30 (2.0)
Kilkenny 30 (2.0)
Clare 28 (1.9)
Westmeath 27 (1.8)
Cavan 26 (1.8)
Tipperary (SR) 25 (1.7)
Donegal 18 (1.2)
Offaly 15 (1.0)
Wicklow 19 (0.9)
Mayo 13 (0.9)
Tipperary (NR) 13 (0.9)
Roscommon 12 (0.8)
Laois 11 (0.7)
Sligo 9 (0.6)
Longford 5 (0.3)
Monaghan 5 (0.3)
Leitrim 3 (0.2)
County unknown 2 (0.0)
* Excludes cases not normally resident in Ireland.
The average annual incidence of new cases treated for cocaine as their main problem substance was 
examined by county for the period 2002 to 2007 (Figure 3). The average incidence for the period was 
highest in Wexford, Louth, Waterford and Carlow, (with over 15 cases per 100,000 of the 15–64-year-old 
population) followed by Cork, Cavan, Limerick, Kildare and Meath (with between 10 and 13 cases per 
100,000). The average incidence was lowest in counties located mainly in the west and north-west of the 
country (with between 2 and 4 cases per 100,000).
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Figure 3 Average annual incidence of cases treated for cocaine as a main problem substance, per 
100,000 15–64-year-olds, by county of residence (NDTRS 2002–2007; CSO 2007, 2008)
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The highest numbers of new cases reporting cocaine as their main problem substance between 2002 and 
2007 lived in Cork, Dublin South West and Wexford local health office (LHO) areas (Table 10). The lowest 
number lived in the Dublin South LHO area. 
Table 10 New cases entering treatment* who reported cocaine as their main problem substance, 
by local health office (LHO) area of residence (NDTRS 2002–2007)
LHO area of residence Number (%)
All new cases 1483 (100.0)
Cork 258 (17.4)
Dublin South West 112 (7.6)
Wexford 111 (7.5)
Kildare and South West Wicklow 85 (5.7)
Limerick 81 (5.5)
Louth 80 (5.4)
Waterford 76 (5.1)
Carlow and Kilkenny 64 (4.3)
Meath 63 (4.2)
North West Dublin 60 (4.0)
North Dublin 58 (3.9)
Dublin North Central 56 (3.8)
Galway 40 (2.7)
Dublin West 35 (2.4)
Longford and Westmeath 32 (2.2)
Cavan and Monaghan 31 (2.1)
Kerry 30 (2.0)
Clare 28 (1.9)
Dublin South City 28 (1.9)
Laois and Offaly 26 (1.8)
Tipperary SR 25 (1.7)
Donegal 18 (1.2)
Mayo 13 (0.9)
Tipperary NR 13 (0.9)
Wicklow (east coast) 13 (0.9)
Dublin South East 12 (0.8)
Roscommon 12 (0.8)
Sligo and Leitrim 12 (0.8)
Dublin South 9 (0.6)
LHO area unknown 2 (0.1)
* Excludes cases not normally resident in Ireland.
The average annual incidence of new cases treated for cocaine as their main problem substance was 
examined by local health office area for the period 2002 to 2007 (Figure 4). The incidence was highest 
in the Wexford, Louth, Dublin South West and Waterford LHO areas (with over 15 cases per 100,000 of 
the 15–64-year-old population) followed by the Cork, and Carlow–Kilkenny LHO areas (with 12.7 cases) 
and the Limerick LHO area (with 12.6 cases). The incidence was lowest in three of the LHO areas in south 
Dublin and in the LHO areas located mainly in the west and north-west of the country (with between 1.7 
and 4.7 cases).
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Figure 4 Average annual incidence of cases treated for cocaine as a main problem substance, per 
100,000 15–64-year-olds, by local health office area of residence (NDTRS 2002–2007; 
CSO 2007, 2008)
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Main problem substance where cocaine was an additional problem substance
The main problem substances associated with cocaine as an additional problem substance were opiates 
and, to a lesser extent, alcohol and cannabis (Table 11). This pattern of use may explain the lower than 
expected incidence rates of cocaine use in counties such as Dublin and Wicklow, where cocaine was 
frequently reported as an additional problem substance and opiates as the main problem substance. 
Table 11 Main problem substance used by cases entering treatment* who reported cocaine as an 
additional problem substance (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Cases reporting cocaine as an 
additional problem substance 826 1084 1274 1516 1712 1885
Main problem substance where 
cocaine was an additional 
problem substance n (%) n (%) n (%) n (%) n (%) n (%)
Opiates 603 (73.0) 773 (71.3) 746 (58.6) 799 (52.7) 957 (55.9) 953 (50.6)
Alcohol n.a.† n.a.† 252 (19.8) 385 (25.4) 359 (21.0) 537 (28.5)
Cannabis 164 (19.9) 224 (20.7) 184 (14.4) 248 (16.4) 316 (18.5) 276 (14.6)
Ecstasy 44 (5.3) 66 (6.1) 61 (4.8) 46 (3.0) 42 (2.5) 51 (2.7)
Benzodiazepines 5 (0.6) 7 (0.6) 20 (1.6) 18 (1.2) 18 (1.1) 38 (2.0)
Amphetamines 8 (1.0) 9 (0.8) 4 (0.3) 10 (0.7) 9 (0.5) 13 (0.7)
Cocaine‡ 0 (0.0) 1 (0.1) 3 (0.2) 9 (0.6) 9 (0.5) 12 (0.6)
Volatile inhalants 0 (0.0) 2 (0.2) 0 (0.0) 0 (0.0) 2 (0.1) 3 (0.2)
Other 2 (0.2) 2 (0.2) 4 (0.3) 1 (0.1) 0 (0.0) 2 (0.1)
* Excludes cases not normally resident in Ireland.
† Not available; the NDTRS did not record alcohol as a main problem substance prior to 2004.
‡ A small number of cases reported one form of cocaine as an additional problem substance and another form of cocaine as their main 
problem substance.
Additional problem substances where cocaine was the main problem substance
The proportion of cases who reported cocaine as their main problem substance and reported use of more 
than one drug decreased from 92% in 2002 to 79% in 2007 (Table 12). The same trend was noted among 
new and previously treated cases. It is generally accepted that polysubstance use increases the complexity 
of these cases and is associated with poorer treatment outcomes.
Table 12 Polysubstance use by cases entering treatment* who reported cocaine as their main 
problem substance, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Polysubstance use n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
All cases who used more than one 
drug 118 (92.2) 233 (92.1) 285 (86.1) 360 (77.1) 458 (83.0) 610 (79.2)
Previously treated cases 56 96 119 175 194 290
Previously treated cases who used 
more than one drug 50 (89.3) 87 (90.6) 97 (81.5) 129 (73.7) 165 (85.1) 233 (80.3)
New cases 61 148 195 275 342 462
New cases who used more than 
one drug 57 (93.4) 137 (92.6) 174 (89.2) 218 (79.3) 281 (82.2) 366 (79.2)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
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Of the cases treated in 2007 who reported cocaine as their main problem substance, 31% reported 
problem use of two substances, 30% of three and 19% of four or more (Table 13). Cases with cocaine as 
their main problem substance most commonly reported three substances as part of their current problem 
substance use. The trends were similar for previously treated and new cases. 
Table 13 Number of problem substances used by cases entering treatment* who reported cocaine 
as their main problem substance, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Number of problem 
substances used n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
One drug 10 (7.8) 20 (7.9) 46 (13.9) 107 (22.9) 94 (17.0) 160 (20.8)
Two drugs 44 (34.4) 77 (30.4) 98 (29.6) 121 (25.9) 157 (28.4) 237 (30.8)
Three drugs 48 (37.5) 80 (31.6) 108 (32.6) 132 (28.3) 165 (29.9) 230 (29.9)
Four drugs 26 (20.3) 76 (30.0) 79 (23.9) 107 (22.9) 136 (24.6) 143 (18.6)
Previously treated cases 56 96 119 175 194 290
One drug 6 (10.7) 9 (9.4) 22 (18.5) 46 (26.3) 29 (14.9) 57 (19.7)
Two drugs 20 (35.7) 31 (32.3) 37 (31.1) 48 (27.4) 54 (27.8) 95 (32.8)
Three drugs 20 (35.7) 29 (30.2) 38 (31.9) 45 (25.7) 66 (34.0) 77 (26.6)
Four drugs 10 (17.9) 27 (28.1) 22 (18.5) 36 (20.6) 45 (23.2) 61 (21.0)
New cases 61 148 195 275 342 462
One drug 4 (6.6) 11 (7.4) 21 (10.8) 57 (20.7) 61 (17.8) 96 (20.8)
Two drugs 18 (29.5) 44 (29.7) 56 (28.7) 67 (24.4) 98 (28.7) 132 (28.6)
Three drugs 23 (37.7) 45 (30.4) 62 (31.8) 84 (30.5) 93 (27.2) 152 (32.9)
Four drugs 16 (26.2) 48 (32.4) 56 (28.7) 67 (24.4) 90 (26.3) 82 (17.7)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
Table 14 presents the additional problem substances used by those who reported cocaine as their main 
problem substance and who used more than one drug. Cannabis, alcohol and ecstasy, in that order, were 
the most common additional problem substances reported by cocaine cases entering treatment in the 
period 2002–2007. The number of cases reporting cannabis as an additional problem substance increased 
by over 300% during the reporting period; the number reporting alcohol increased by 719%. The use of 
alcohol and cocaine together leads to the formation of a third drug, cocaethylene, which is a more stable 
compound than the normal by-product of cocaine and is effective for longer in the body. There is evidence 
to show that cocaethylene increases the incidence and intensity of the cardiovascular and the behavioural 
side effects of cocaine.
The most frequently used additional problem substances reported by previously treated cases in the period 
under review were alcohol, cannabis and opiates. New cases entering treatment reported cannabis, alcohol 
and ecstasy as the most commonly used additional problem substances. 
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Table 14 Additional problem substances used by cases entering treatment* who reported cocaine 
as their main problem substance, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Additional problem 
substances used† n (%) n (%) n (%) n (%) n (%) n (%)
All cases 118 233 285 360 458 610
Cannabis 83 (70.3) 143 (61.4) 161 (56.5) 225 (62.5) 270 (59.0) 356 (58.4)
Alcohol 42 (35.6) 99 (42.5) 140 (49.1) 185 (51.4) 293 (64.0) 344 (56.4)
Ecstasy 41 (34.7) 95 (40.8) 105 (36.8) 129 (35.8) 148 (32.3) 194 (31.8)
Opiates 28 (23.7) 63 (27.0) 73 (25.6) 68 (18.9) 65 (14.2) 94 (15.4)
Benzodiazepines 10 (8.5) 19 (8.2) 37 (13.0) 35 (9.7) 54 (11.8) 69 (11.3)
Amphetamines 5 (4.2) 30 (12.9) 27 (9.5) 43 (11.9) 43 (9.4) 36 (5.9)
Cocaine‡ 0 (0.0) 1 (0.4) 3 (1.1) 9 (2.5) 9 (2.0) 12 (2.0)
Volatile inhalants 0 (0.0) 0 (0.0) 1 (0.4) 2 (0.6) 1 (0.2) 3 (0.5)
Other 8 (6.8) 13 (5.6) 3 (1.1) 6 (1.7) 9 (2.0) 14 (2.3)
Previously treated cases 50 87 97 129 165 233
Alcohol 18 (36.0) 34 (39.1) 34 (35.1) 60 (46.5) 101 (61.2) 131 (56.2)
Cannabis 28 (56.0) 41 (47.1) 37 (38.1) 59 (45.7) 88 (53.3) 116 (49.8)
Opiates 20 (40.0) 41 (47.1) 65 (67.0) 52 (40.3) 39 (23.6) 66 (28.3)
Benzodiazepines 6 (12.0) 15 (17.2) 19 (19.6) 14 (10.9) 29 (17.6) 35 (15.0)
Ecstasy 12 (24.0) 26 (29.9) 20 (20.6) 36 (27.9) 38 (23.0) 55 (23.6)
Cocaine‡ 0 (0.0) 0 (0.0) 1 (1.0) 5 (3.9) 4 (2.4) 10 (4.3)
Amphetamines 1 (2.0) 7 (8.0) 3 (3.1) 16 (12.4) 19 (11.5) 10 (4.3)
Volatile inhalants 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.4)
Other 5 (10.0) 5 (5.7) 0 (0.0) 3 (2.3) 3 (1.8) 6 (2.6)
New cases 57 137 174 218 281 366
Cannabis 47 (82.5) 96 (70.1) 115 (66.1) 157 (72.0) 174 (61.9) 236 (64.5)
Alcohol 23 (40.4) 60 (43.8) 99 (56.9) 117 (53.7) 186 (66.2) 209 (57.1)
Ecstasy 25 (43.9) 67 (48.9) 82 (47.1) 90 (41.3) 109 (38.8) 139 (38.0)
Benzodiazepines 4 (7.0) 3 (2.2) 16 (9.2) 20 (9.2) 23 (8.2) 34 (9.3)
Amphetamines 4 (7.0) 22 (16.1) 24 (13.8) 26 (11.9) 24 (8.5) 26 (7.1)
Opiates 7 (12.3) 21 (15.3) 6 (3.4) 14 (6.4) 23 (8.2) 24 (6.6)
Cocaine‡ 0 (0.0) 1 (0.7) 2 (1.1) 4 (1.8) 5 (1.8) 2 (0.5)
Volatile inhalants 0 (0.0) 0 (0.0) 1 (0.6) 2 (0.9) 1 (0.4) 2 (0.5)
Other 1 (1.8) 7 (5.1) 2 (1.1) 3 (1.4) 6 (2.1) 8 (2.2)
Treatment status unknown 11 9 14 13 12 11
* Excludes cases not normally resident in Ireland.
† By cases reporting use of one, two or three additional drugs
‡ Thirty-four cases reported one form of cocaine as their main problem substance and another form of cocaine as an additional 
problem substance. 
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Patterns of cocaine use
In 2007, of the 770 cases who reported cocaine as their main problem substance, 81% snorted it, 13% 
smoked it, and 4% injected it (Table 15). Cocaine powder is usually snorted, while crack cocaine is usually 
smoked; both forms of cocaine can be injected. The proportion of cases who injected cocaine decreased 
considerably during the reporting period. The proportion of injectors was higher among previously treated 
cases than among new cases. It is likely that those who injected cocaine were former or current opiate 
injectors. 
Table 15 Route of administration for cases entering treatment* who reported cocaine as their main 
problem substance, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Route of administration n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
Inject 23 (18.0) 30 (11.9) 52 (15.7) 45 (9.6) 27 (4.9) 31 (4.0)
Smoke 9 (7.0) 27 (10.7) 29 (8.8) 34 (7.3) 61 (11.1) 101 (13.1)
Eat or drink 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (0.9) 4 (0.5)
Sniff or snort 95 (74.2) 190 (75.1) 244 (73.7) 379 (81.2) 454 (82.2) 621 (80.6)
Not recorded 1 (0.8) 6 (2.4) 6 (1.8) 9 (1.9) 5 (.9) 13 (1.7)
Previously treated cases 56 96 119 175 194 290
Inject 20 (35.7) 25 (26.0) 49 (41.2) 40 (22.9) 22 (11.3) 29 (10.0)
Smoke 4 (7.1) 10 (10.4) 14 (11.8) 12 (6.9) 22 (11.3) 52 (17.9)
Eat or drink 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.5) 0 (0.0)
Sniff or snort 32 (57.1) 59 (61.5) 53 (44.5) 120 (68.6) 147 (75.8) 206 (71.0)
Not recorded 0 (0.0) 2 (2.1) 3 (2.5) 3 (1.7) 2 (1.0) 3 (1.0)
New cases 61 148 195 275 342 462
Inject 2 (3.3) 4 (2.7) 1 (0.5) 3 (1.1) 4 (1.2) 1 (0.2)
Smoke 5 (8.2) 17 (11.5) 12 (6.2) 22 (8.0) 38 (11.1) 46 (10.0)
Eat or drink 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (1.2) 3 (0.6)
Sniff or snort 53 (86.9) 123 (83.1) 180 (92.3) 244 (88.7) 294 (86.0) 405 (87.7)
Not recorded 1 (1.6) 4 (2.7) 2 (1.0) 6 (2.2) 2 (0.6) 7 (1.5)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
In 2007, of the 770 cases who reported cocaine as their main problem substance, 13% used it daily, 44% 
used it on two to six days per week, 11% used it once per week or less and 30% had not used it in the 
month prior to entering treatment (Table 16). The fact that the majority of cases reported using cocaine on 
two to six days per week indicates that cocaine may be used as a week-end drug or as part of a binge. Over 
the reporting period there was a fall in the proportion of cases reporting daily use. Figures for ‘daily’ use 
and for ‘no use’ in the past month were much higher for previously treated cases than for new cases. The 
cases who had not used cocaine in the month prior to treatment were mainly those entering medication-
free therapy.
22 HRB Trends Series 6
Table 16 Frequency of cocaine use in the month prior to entering treatment* by cases who 
reported cocaine as their main problem substance, by treatment status (NDTRS 2002–
2007)
2002 2003 2004 2005 2006 2007
Frequency of use in the month 
prior to treatment n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
Daily 27 (21.1) 61 (24.1) 67 (20.2) 95 (20.3) 83 (15.0) 101 (13.1)
2–6 days per week 48 (37.5) 106 (41.9) 127 (38.4) 197 (42.2) 243 (44.0) 336 (43.6)
Once a week or less 12 (9.4) 22 (8.7) 37 (11.2) 55 (11.8) 73 (13.2) 84 (10.9)
No use in the last month 35 (27.3) 58 (22.9) 83 (25.1) 109 (23.3) 143 (25.9) 229 (29.7)
Not known 6 (4.7) 6 (2.4) 17 (5.1) 11 (2.4) 10 (1.8) 20 (2.6)
Previously treated cases 56 96 119 175 194 290
Daily 13 (23.2) 27 (28.1) 26 (21.8) 46 (26.3) 31 (16.0) 47 (16.2)
2–6 days per week 15 (26.8) 29 (30.2) 43 (36.1) 58 (33.1) 68 (35.1) 100 (34.5)
Once a week or less 8 (14.3) 11 (11.5) 9 (7.6) 19 (10.9) 28 (14.4) 28 (9.7)
No use in the last month 16 (28.6) 27 (28.1) 29 (24.4) 47 (26.9) 63 (32.5) 108 (37.2)
Not known 4 (7.1) 2 (2.1) 12 (10.1) 5 (2.9) 4 (2.1) 7 (2.4)
New cases 61 148 195 275 342 462
Daily 10 (16.4) 33 (22.3) 38 (19.5) 45 (16.4) 49 (14.3) 52 (11.3)
2–6 days per week 28 (45.9) 69 (46.6) 80 (41.0) 131 (47.6) 171 (50.0) 231 (50.0)
Once a week or less 3 (4.9) 11 (7.4) 26 (13.3) 35 (12.7) 43 (12.6) 53 (11.5)
No use in the last month 19 (31.1) 31 (20.9) 47 (24.1) 60 (21.8) 74 (21.6) 116 (25.1)
Not known 1 (1.6) 4 (2.7) 4 (2.1) 4 (1.5) 5 (1.5) 10 (2.2)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
Between 2002 and 2007, the median age at which new cocaine cases commenced use of any illicit drug 
was 15 years (Table 17). The median age at which new cases commenced cocaine use was 19 years. Half 
of the new cocaine cases had used cocaine for four years or more before seeking treatment. These findings 
indicate that cocaine cases often used other drugs prior to commencing cocaine use and that they used 
cocaine for a considerable period before seeking treatment. The median age at first cocaine use was similar 
to the median age at first opiate use. 
Table 17 Median age (range) at significant points, and time between first use of cocaine and entry 
into treatment for new cases* who reported cocaine as their main problem substance 
(NDTRS 2002–2007)
New cases reporting 
cocaine as their main 
problem substance 
(n=1477)
Age first used any 
drug (n=1394)
Age first used cocaine 
(n=1360)
Age first sought 
treatment for cocaine 
use (n=1477)
Years between first 
used cocaine and first 
entered treatment 
(n=1360)
Median age (range†) 15 (12–24) 19 (15–30) 24 (18–38) 4 (0–13)
* Excludes cases not normally resident in Ireland.
† Age range presented is 5th percentile to 95th percentile (90% of cases are included within this range).
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Socio-demographic characteristics
The median age of previously treated cases entering treatment for cocaine as their main problem substance 
decreased from 28 to 27 years between 2002 and 2007, while the median age of new cases decreased by 
two years, from 25 to 23 years (Table 18). In 2007, 5% of new cases were under 18 years of age, while 
just over 2% of previously treated cases were in this age group. The proportion of new cases aged under 
18 years increased noticeably in 2007, which may be due to an increase in the provision of in adolescent 
treatment services in 2007. In the same year, 84% of cases entering treatment for cocaine as their main 
problem substance were male. In 2007, the proportion of cocaine cases who reported leaving school early 
was higher among previously treated cases (18%) than among new cases (12%). In the same year, one-
third of treated cocaine cases were employed. Each year small proportions of cocaine cases reported being 
homeless. 
Table 18 Socio–economic characteristics of cases entering treatment* who reported cocaine as their 
main problem substance, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Characteristics of cases† n (%) n (%) n (%) n (%) n (%) n (%)
All cases 128 253 331 467 552 770
Median age (range‡) 27 (18-43) 26 (18-39) 24 (17-38) 25 (18-39) 25 (18-39) 25 (18-39)
Under 18 years ~ 7 (2.8) 17 (5.1) 11 (2.4) 15 (2.7) 31 (4.0)
Male 107 (83.6) 207 (81.8) 258 (77.9) 381 (81.6) 469 (85.0) 649 (84.3)
Living with parents and 
family 68 (53.1) 119 (47.0) 190 (57.4) 273 (58.5) 296 (53.6) 415 (53.9)
Homeless 7 (5.5) 12 (4.7) 12 (3.6) 14 (3.0) 25 (4.5) 29 (3.8)
Non-Irish nationals ~ 12 (4.7) ~ 9 (1.9) 11 (2.0) 18 (2.3)
Early school leavers 26 (20.3) 44 (17.4) 50 (15.1) 80 (17.1) 91 (16.5) 113 (14.7)
Still at school ~ ~ 10 (3.0) 9 (1.9) 5 (0.9) 17 (2.2)
Employed (aged 16–64) 44 (34.4) 61 (24.2) 111 (34.0) 150 (32.4) 194 (35.4) 268 (35.3)
Previously treated cases 56 96 119 175 194 290
Median age (range‡) 28 (20-44) 27 (19-38) 26 (20-38) 27 (18-40) 26 (18-40) 27 (18-42)
Under 18 years ~ ~ ~ ~ 7 (3.6) 7 (2.4)
Male 47 (83.9) 71 (74.0) 82 (68.9) 143 (81.7) 168 (86.6) 247 (85.2)
Living with parents and 
family 26 (46.4) 51 (53.1) 61 (51.3) 93 (53.1) 101 (52.1) 137 (47.2)
Homeless 5 (8.9) ~ ~ 7 (4.0) 9 (4.6) 11 (3.8)
Non-Irish nationals ~ ~ ~ 6 (3.4) ~ ~
Early school leavers 15 (26.8) 20 (20.8) 25 (21.0) 49 (28.0) 44 (22.7) 53 (18.3)
Still at school ~ ~ ~ ~ ~ ~
Employed (aged 16–64) 11 (19.6) 19 (19.8) 27 (22.7) 36 (20.7) 48 (24.9) 87 (30.2)
New cases 61 148 195 275 342 462
Median age (range‡) 25 (18-43) 25 (18-41) 22 (16-36) 24 (18-38) 24 (18-37) 23 (17-35)
Under 18 years ~ ~ 17 (8.7) 9 (3.3) 8 (2.3) 23 (5.0)
Male 51 (83.6) 128 (86.5) 163 (83.6) 226 (82.2) 287 (83.9) 386 (83.5)
Living with parents and 
family 35 (57.4) 65 (43.9) 119 (61.0) 170 (61.8) 185 (54.1) 271 (58.7)
Homeless ~ 7 (4.7) 8 (4.1) 7 (2.5) 16 (4.7) 17 (3.7)
Non-Irish nationals ~ 8 (5.4) ~ ~ 7 (2.0) 12 (2.6)
Early school leavers 7 (11.5) 23 (15.5) 23 (11.8) 29 (10.5) 43 (12.6) 57 (12.3)
Still at school ~ ~ 10 (5.1) 9 (3.3) 5 (1.5) 16 (3.5)
Employed (aged 16–64) 27 (44.3) 40 (27.2) 81 (42.6) 109 (40.1) 141 (41.6) 175 (38.5)
Treatment status unknown 11 9 17 17 16 18
* Excludes cases not normally resident in Ireland.
† It is not possible to ascertain the percentage with each characteristic of interest from the total number because not all forms had 
complete data. 
‡ Age range presented is 5th percentile to 95th percentile (90% of cases are included within this range).
~ Numbers of cases less than five cannot be reported. 
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Treatment provision
Of the 770 cases entering treatment who reported cocaine as their main problem substance in 2007, 84% 
received counselling, 43% a brief intervention, 31% complementary therapy and 27% medication-free 
therapy (Figure 5). Almost 60% of cases received more than one initial treatment intervention (Figure 6). It 
is widely recognised that no single intervention will effectively treat problem cocaine use. It is important to 
note that the NDTRS form records only the initial treatment provided in each case. Treatment interventions 
that may be provided subsequently are not recorded. In recent years there has been an increase in the 
types of intervention provided and a greater emphasis on brief intervention, counselling (including 
cognitive behaviour therapy), family therapy, aftercare and social re-integration. Alcohol detoxification 
and methadone substitution were provided for some cases who reported alcohol or opiates as additional 
problem substances.
Figure 5 Percentage of cases entering treatment who reported cocaine as their main problem 
substance, by type of initial treatment intervention availed of (NDTRS 2007)
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Figure 6 Percentage of cases entering treatment who reported cocaine as their main problem 
substance, by the number of treatment interventions availed of (NDTRS 2007)
Conclusions
The number of cases entering treatment and reporting cocaine as their main problem substance or as 
an additional problem substance increased steadily between 2002 and 2007. The higher incidence of 
treatment for cocaine as a main problem substance was in the north-eastern, south eastern and southern 
counties. In Dublin, cocaine was reported as an additional problem to opiates. The increase in treated 
cocaine cases was in line with increases in cocaine seizures, in cocaine use among the general population 
and in cocaine-related deaths. It was also in line with an increase in treatment interventions for cocaine 
users and an increase in reporting to the NDTRS.
Almost four out of five cases who reported cocaine as their main problem substance used more than 
one drug. Cocaine was used alongside opiates, cannabis, alcohol and ecstasy. There appeared to be two 
profiles of cocaine user entering treatment, those who used opiates alongside cocaine and those who 
used combinations of alcohol, cannabis and ecstasy alongside cocaine. The majority of cases who reported 
cocaine as their main problem substance used it on two to six days per week, indicating that cocaine may 
be used as a week-end drug or a part of a binge. Half of the cases were under 27 years old; 83% were men 
and 33% were employed. The proportion of treated cocaine cases in employment was higher than the 
proportion reported for treated opiate cases, 35% versus 13%, and the proportion of treated cocaine cases 
who left school early was lower than the proportion reported for treated opiate cases, 15% versus 25%, 
indicating that treated cocaine users had a mixed social profile while opiate cases had a deprived social 
profile. Sixty-nine per cent of cocaine users were treated at outpatient services. There is a wide variety of 
interventions provided to cocaine cases, but until there are national data on immediate treatment outcome 
it is difficult to comment on the effectiveness of these interventions.
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